Home » Medical Devices » UK Cardiovascular Devices Market

UK Cardiovascular Devices Market

UK Cardiovascular Devices Market By Product (Diagnostic & Monitoring Devices, Surgical Devices); By End User (Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others); By Diagnostic & Monitoring Devices Type (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Others); By Surgical Devices Type (Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs), Pacemakers, Coronary Stents, Catheters); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
UK Cardiovascular Devices Market Size 2024	USD 2,982.65 million
UK Cardiovascular Devices Market, CAGR	7.0%
UK Cardiovascular Devices Market Size 2032	USD 5,491.36 million

Market Overview

The UK Cardiovascular Devices Market is projected to grow from USD 2,982.65 million in 2024 to an estimated USD 5,491.36 million by 2032, with a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032. This growth is driven by the rising incidence of cardiovascular diseases, an aging population, and advancements in medical technology.

Key drivers of this market include the growing prevalence of risk factors such as hypertension, obesity, and diabetes, all of which contribute to a higher incidence of cardiovascular conditions. Technological advancements, including minimally invasive procedures, digital health solutions, and the development of next-generation diagnostic devices, are also supporting market growth. Additionally, the increased adoption of wearable devices for heart monitoring and the shift towards home-based care options are transforming the landscape of cardiovascular care.

Geographically, the UK remains a significant player in the European cardiovascular devices market, benefiting from robust healthcare infrastructure and government healthcare initiatives. Key players in the market include Abbott Laboratories, Medtronic, Philips Healthcare, and Boston Scientific, who continue to innovate and expand their product offerings in response to the growing demand for cardiovascular solutions. These companies are focusing on strategic partnerships, technological advancements, and market expansion to maintain their competitive edge.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The UK Cardiovascular Devices Market is projected to grow significantly, reaching USD 5,491.36 million by 2032, driven by increasing cardiovascular diseases and advancements in medical technology.
The global cardiovascular devices market is projected to grow from USD 72,115.60 million in 2024 to USD 133,700.94 million by 2032, with a CAGR of 7.1% from 2025 to 2032, driven by increasing cardiovascular diseases and advancements in medical technology.
The market is propelled by the growing prevalence of hypertension, diabetes, and obesity, all of which are major risk factors for cardiovascular conditions, increasing the demand for diagnostic and therapeutic devices.
Innovations in minimally invasive procedures, wearable devices, and digital health solutions are enhancing patient outcomes and providing more efficient cardiovascular care options.
The UK’s aging population is contributing to a higher incidence of cardiovascular diseases, driving the need for both preventive care and advanced cardiovascular treatment solutions.
High costs of advanced cardiovascular devices may limit their widespread adoption, particularly in underfunded healthcare settings, making affordability a key challenge.
Navigating the complex regulatory and reimbursement frameworks within the UK healthcare system can slow down the market’s expansion, especially for new and innovative devices.
Southern England holds the largest market share, benefiting from robust healthcare infrastructure, while other regions like the Midlands and North are seeing increased demand for cardiovascular care due to growing disease burdens.

Report Scope

This report segments the UK Cardiovascular Devices Market as follows:

Market Drivers

Rising Prevalence of Cardiovascular Diseases (CVDs)

Cardiovascular diseases (CVDs) are a significant health concern in the UK, accounting for a large percentage of healthcare-related deaths. The growing prevalence of conditions such as coronary artery disease, heart failure, and arrhythmias is one of the primary drivers of the UK cardiovascular devices market. According to the British Heart Foundation, for instance, cardiovascular diseases account for around 160,000 deaths per year in the UK. The increasing burden of these diseases is largely attributed to risk factors such as an aging population, poor dietary habits, sedentary lifestyles, and rising obesity rates. As the incidence of CVDs continues to rise, there is an increasing demand for diagnostic devices such as electrocardiograms (ECGs), echocardiograms, and cardiac imaging systems, as well as therapeutic devices like pacemakers, stents, and defibrillators to manage these conditions effectively. The urgency for preventive care and early diagnosis has pushed the adoption of advanced cardiovascular devices, fostering market growth.

Technological Advancements in Cardiovascular Devices

Technological innovations in cardiovascular devices play a pivotal role in the growth of the market. Over the past decade, there has been a significant shift toward more efficient, minimally invasive devices, which has improved patient outcomes and reduced recovery times. In the UK, advancements such as transcatheter aortic valve replacement (TAVR), bioabsorbable stents, and wearable ECG monitors are revolutionizing the cardiovascular space. For instance, AI-powered ECG machines are now being used in UK hospitals to enhance early detection of arrhythmias and other heart conditions. These advancements allow for less invasive procedures, lower risks of complications, and quicker recovery periods compared to traditional open-heart surgeries. Furthermore, the integration of digital health technologies into cardiovascular devices is enhancing the management of heart disease. The increasing use of mobile health applications, wearable ECG monitors, and remote patient monitoring systems is empowering healthcare providers and patients with real-time data for better decision-making. For instance, UK hospitals have adopted AI-driven cardiac imaging systems to improve diagnostic accuracy and treatment planning. Innovations in AI and machine learning are also being applied to enhance diagnostic accuracy and predictive analytics, making cardiovascular care more personalized and effective. As these technological advancements continue to develop, they create a more efficient healthcare system and increase the adoption of advanced cardiovascular devices in the UK.

Aging Population and Increasing Healthcare Expenditure

The aging population in the UK is a critical driver of the cardiovascular devices market. As life expectancy increases, the number of elderly individuals with cardiovascular diseases also rises. The elderly population is particularly vulnerable to heart conditions due to the natural aging process, which leads to a decline in heart function and increased susceptibility to diseases like hypertension and atherosclerosis. With the UK’s population rapidly aging, there is a growing need for cardiovascular devices tailored to meet the needs of older adults. Furthermore, an aging population places greater strain on the healthcare system, necessitating the adoption of more efficient and cost-effective medical technologies, including cardiovascular devices. The UK government and private healthcare providers are increasingly focusing on improving access to healthcare for the elderly, leading to increased healthcare spending and investments in cardiovascular care. The increased demand for cardiovascular devices is a direct result of this demographic shift, as healthcare providers seek to implement more effective interventions for the growing elderly population.

Government Initiatives and Healthcare Investments

Government policies and investments in the UK healthcare system are also playing a significant role in driving the cardiovascular devices market. The National Health Service (NHS), which is the publicly funded healthcare system in the UK, has made significant investments in cardiovascular care, including the acquisition of advanced diagnostic equipment and therapeutic devices. These investments are driven by the government’s commitment to improving healthcare outcomes and reducing the financial burden of chronic diseases, including cardiovascular conditions. Additionally, the NHS has made strides in expanding access to cardiovascular care, ensuring that individuals, particularly those in underserved areas, have access to the latest technologies and treatments. On a broader scale, the UK government has introduced initiatives aimed at reducing the burden of cardiovascular diseases through public health campaigns that focus on prevention, lifestyle modifications, and early diagnosis. These initiatives support the adoption of cardiovascular devices by promoting awareness and providing funding to healthcare providers, hospitals, and research institutions. As a result, government-backed initiatives are expected to contribute significantly to the growth of the cardiovascular devices market in the UK, improving patient outcomes and encouraging technological innovation.

Market Trends

Adoption of Minimally Invasive Procedures

Minimally invasive procedures are gaining traction in the UK cardiovascular devices market, as they offer significant advantages over traditional open-heart surgeries. These procedures, which include techniques like transcatheter aortic valve replacement (TAVR) and percutaneous coronary interventions (PCI), involve smaller incisions, reduced recovery times, and lower risk of complications. The demand for devices enabling these procedures, such as catheter-based technologies, stents, and bioabsorbable materials, is rising. For instance, UK hospitals have increasingly adopted robotic-assisted catheter procedures to enhance precision and patient outcomes. Additionally, healthcare facilities are investing in hybrid operating rooms that integrate real-time imaging with interventional cardiology, improving procedural accuracy and efficiency. With a growing focus on patient comfort and rapid recovery, the trend toward minimally invasive interventions is transforming cardiovascular care in the UK. Healthcare professionals are increasingly choosing these procedures as they enhance precision, reduce trauma, and allow for quicker discharge from hospitals, leading to cost savings in the long term. Additionally, patients’ preference for less invasive options, supported by advancements in device technology, is further driving this trend, making it a crucial component of the market’s growth trajectory.

Integration of Digital Health Technologies

Digital health technologies are increasingly integrated into cardiovascular devices, revolutionizing how heart disease is monitored and managed in the UK. Wearable devices, mobile apps, and remote patient monitoring systems allow real-time monitoring of vital signs, such as heart rate, blood pressure, and electrocardiogram (ECG) data. These technologies enable healthcare providers to track patient conditions remotely, making early interventions possible and improving patient outcomes. For instance, AI-powered ECG analysis tools are now being deployed in UK hospitals to enhance diagnostic accuracy and streamline patient management. Additionally, AI and machine learning are enhancing diagnostic accuracy and predictive analytics, offering personalized treatment plans. The UK healthcare system is embracing this shift toward digital health solutions as they help optimize care management, reduce hospital visits, and provide more efficient use of healthcare resources. The demand for connected cardiovascular devices is expected to grow, supported by the National Health Service (NHS) initiatives aimed at expanding digital healthcare solutions.

Focus on Preventive Cardiovascular Care

Preventive cardiovascular care is becoming a dominant trend in the UK as healthcare providers and patients focus on early detection and risk mitigation to combat the rising burden of heart disease. There is increasing emphasis on screenings for hypertension, cholesterol levels, and diabetes as key risk factors for cardiovascular disease. With a growing awareness of lifestyle-related heart conditions, healthcare providers are leveraging advanced diagnostic devices to identify risks at an early stage. This proactive approach aims to reduce the need for invasive treatments later in life, promoting healthier lifestyles and less reliance on expensive interventions. Cardiovascular devices, such as home monitoring devices and point-of-care diagnostic tools, are helping to detect potential issues early, enabling individuals to take control of their health. Preventive care is further supported by NHS programs and public health campaigns aimed at reducing the incidence of preventable heart diseases across the UK.

Rising Demand for Wearable Cardiovascular Devices

Wearable cardiovascular devices are increasingly popular in the UK due to their ability to provide continuous monitoring and real-time data. These devices, including smartwatches and fitness trackers that offer heart rate monitoring, ECG recording, and even blood oxygen level tracking, are gaining acceptance not only for fitness but also for medical purposes. Wearables enable patients to monitor their heart health outside of clinical settings, helping to detect irregularities such as arrhythmias or irregular heartbeats at the earliest signs. These devices are becoming essential in both prevention and post-treatment care, offering significant benefits for managing chronic conditions and improving patient outcomes. The UK market for wearable cardiovascular devices is experiencing rapid growth, driven by advancements in sensor technology, improved accuracy, and increasing consumer awareness of the benefits of monitoring heart health regularly. This trend is further supported by growing healthcare system initiatives focused on encouraging self-management of cardiovascular health through wearable devices.

Market Challenges

High Cost of Advanced Cardiovascular Devices

One of the primary challenges facing the UK cardiovascular devices market is the high cost associated with advanced technologies. Cardiovascular devices, especially those used in minimally invasive procedures and diagnostic tools like advanced stents, pacemakers, and TAVR systems, come with substantial upfront costs. These high prices pose significant barriers to widespread adoption, particularly for smaller healthcare institutions or those with limited funding. Although these devices are designed to improve patient outcomes, reduce recovery times, and enhance overall efficiency, their high price point makes them less accessible in certain regions or for patients without comprehensive insurance coverage. Moreover, the increasing demand for cutting-edge cardiovascular devices has led to greater pressure on healthcare budgets, especially within the National Health Service (NHS). As the NHS works to optimize its resources, there is a growing challenge of balancing the integration of expensive yet essential technologies with the need to maintain affordable, accessible healthcare services for all UK residents. For instance, UK hospitals have increasingly adopted AI-powered cardiovascular diagnostic tools to enhance early detection of heart diseases, but cost barriers have slowed their widespread implementation. This cost barrier may slow the market’s growth, particularly in regions where healthcare funding is more limited or where alternative, less expensive solutions are preferred. In 2024, UK-based medical technology firms introduced robotic-assisted cardiovascular surgery systems designed to improve precision and patient outcomes, yet their adoption has been gradual due to cost concerns. Additionally, the ongoing economic pressures exacerbated by the COVID-19 pandemic further strain the NHS and private sector budgets, making cost-effective decision-making crucial for future market expansion.

Regulatory and Reimbursement Challenges

Navigating the regulatory landscape and reimbursement policies is another significant challenge in the UK cardiovascular devices market. The process of gaining regulatory approval for new cardiovascular devices can be lengthy and complex, involving stringent assessments from regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA). These regulations are essential to ensure patient safety, but they also extend the time to market for innovative devices, delaying the availability of potentially life-saving technologies. Moreover, reimbursement policies in the UK can vary, with certain devices facing reimbursement hurdles. While the NHS covers many medical procedures and treatments, the reimbursement process for high-tech cardiovascular devices can be inconsistent. This inconsistency can create barriers to market access, as some devices may not be fully covered or may require patients to pay out-of-pocket costs, making them less accessible to certain populations. Additionally, with ongoing budget constraints, the NHS is increasingly focused on value-based care, demanding that new devices demonstrate clear cost-effectiveness and improved patient outcomes. These factors may deter manufacturers from investing heavily in the UK market or slow the adoption of new technologies, as companies must navigate the complexities of gaining approval and securing adequate reimbursement for their products.

Market Opportunities

Growing Demand for Remote Patient Monitoring and Wearable Devices

A significant market opportunity in the UK cardiovascular devices market lies in the increasing demand for remote patient monitoring and wearable devices. With advancements in digital health technology, wearables such as smartwatches and portable ECG monitors are gaining popularity for continuous cardiovascular monitoring. These devices provide real-time data on heart rate, blood pressure, and electrocardiogram (ECG) readings, enabling early detection of potential heart issues. The UK’s healthcare system, especially the National Health Service (NHS), is increasingly adopting remote monitoring solutions to reduce hospital visits and improve patient management outside clinical settings. As the healthcare system shifts towards more patient-centric, preventative care, there is a growing opportunity for manufacturers to develop and introduce wearable cardiovascular devices that offer real-time monitoring, predictive analytics, and seamless integration with healthcare providers’ systems. The UK’s aging population, combined with the rising awareness of heart health, positions the market for wearable cardiovascular devices to expand significantly, providing a profitable avenue for growth.

Expansion of Minimally Invasive Procedures and Technological Advancements

The rise in minimally invasive procedures presents another promising opportunity for the UK cardiovascular devices market. Technologies such as bioabsorbable stents, transcatheter valve replacements, and robotic-assisted cardiac surgery are transforming the way cardiovascular conditions are treated. These procedures offer reduced recovery times, lower risks, and enhanced precision compared to traditional surgeries, making them increasingly favored by both healthcare providers and patients. As the demand for minimally invasive interventions continues to grow, manufacturers have the opportunity to innovate and introduce advanced cardiovascular devices that enhance procedure outcomes. With the UK’s healthcare system focusing on improving patient outcomes and reducing hospital stays, there is significant market potential for devices that enable safer, more efficient, and less invasive cardiovascular treatments.

Market Segmentation Analysis

By Product

The UK cardiovascular devices market is primarily segmented based on product type, which includes diagnostic and monitoring devices and surgical devices. Diagnostic and monitoring devices are essential for the early detection and ongoing management of cardiovascular diseases. These devices include electrocardiographs (ECGs), echocardiographs, stress test systems, and blood pressure monitors. With the rising prevalence of heart diseases, the demand for these devices has surged as healthcare providers focus on early diagnosis, patient monitoring, and preventive care. On the other hand, surgical devices, which include pacemakers, stents, defibrillators, and heart valve replacements, are integral in the treatment of cardiovascular conditions. Minimally invasive procedures using these devices have gained significant traction in the UK, as they offer faster recovery times and reduced risks for patients. The demand for both categories of devices is closely tied to the aging population and the increasing burden of heart-related conditions in the country.

By End User

The UK cardiovascular devices market is also segmented based on the end user, with major segments including hospitals and clinics, diagnostic laboratories, and ambulatory surgical centers. Hospitals and clinics represent the largest segment, as they are the primary facilities for diagnosing, treating, and managing cardiovascular diseases. These healthcare settings rely on a wide range of cardiovascular devices for both preventive care and treatment. Diagnostic laboratories play a crucial role in the early detection and monitoring of cardiovascular diseases, utilizing diagnostic devices to assess patients’ heart health. The increasing emphasis on diagnostic accuracy and the growing demand for preventive care in the UK contribute to the growth of this segment. Ambulatory surgical centers are gaining momentum due to the rise in outpatient surgeries and minimally invasive procedures, which require specialized cardiovascular devices. These centers offer an efficient, cost-effective alternative to traditional hospitals and are particularly beneficial for patients requiring routine cardiovascular treatments. Other end users include home care settings, where wearable devices and remote monitoring systems are increasingly being used to track heart health outside of clinical environments.

Segments

Based on Product

Diagnostic & Monitoring Devices
Surgical Devices

Based on End User

Hospitals & Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers
Others

Based on Diagnostic & Monitoring Devices Type

ECG
Implantable Cardiac Monitors
Holter Monitors
Mobile Cardiac Telemetry
MRI
Others

Based on Surgical Devices Type

Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs
Pacemakers
Coronary Stents
Catheters

Based on Region

Southern England
Midlands and North of England
Southwest and Wales
Scotland

Regional Analysis

Southern England (45%)

Southern England, particularly London, holds the largest market share within the UK cardiovascular devices market, accounting for approximately 45% of the overall market share. This region benefits from the presence of world-renowned healthcare institutions, such as the Royal Brompton Hospital and St Thomas’ Hospital, which are leading centers for cardiovascular research, diagnostics, and treatment. With a highly developed healthcare infrastructure, Southern England is a hub for cutting-edge medical technologies, including minimally invasive cardiovascular devices and advanced diagnostic equipment. The region’s high healthcare spending, coupled with a growing demand for specialized cardiovascular care due to an aging population, supports its dominance in the market. Furthermore, London’s central role in healthcare innovation and its access to international expertise contribute significantly to its market share.

Midlands and North of England (30%)

The Midlands and North of England collectively account for approximately 30% of the UK cardiovascular devices market. While not as dominant as Southern England, these regions are experiencing rapid growth due to increasing investments in healthcare infrastructure and the adoption of advanced cardiovascular technologies. The Midlands has witnessed a surge in cardiovascular disease rates, prompting a heightened focus on prevention and early detection, thus increasing the demand for diagnostic and monitoring devices. Additionally, the region is seeing an uptick in the adoption of minimally invasive procedures, supported by the increasing presence of outpatient surgical centers and local hospitals implementing advanced cardiac care technologies. In the North of England, areas like Manchester and Leeds are growing as healthcare hubs, contributing to the rise in demand for both diagnostic and surgical cardiovascular devices.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Abbott
GE HealthCare
Edwards Lifesciences Corporation
L. Gore & Associates, Inc.
Siemens Healthcare GmbH
BIOTRONIK SE & Co. KG
Canon Medical Systems Asia Pte. Ltd.
Cardinal Health
Medtronic
Boston Scientific Corporation
Johnson & Johnson Services, Inc.
Flexicare
R. Bard (now part of BD)
Smith & Nephew
LivaNova

Competitive Analysis

The UK cardiovascular devices market is highly competitive, with major players such as Abbott, Medtronic, and Boston Scientific leading the industry. These companies leverage strong product portfolios, including advanced diagnostic tools, stents, pacemakers, and other therapeutic devices, to capture a significant market share. Abbott and Medtronic, for instance, are renowned for their innovation in minimally invasive procedures, driving demand for their cutting-edge technologies. Edwards Lifesciences and Boston Scientific are particularly strong in heart valve technologies and electrophysiology. The market is also witnessing increased competition from emerging players like LivaNova and BIOTRONIK, which focus on specific niches such as cardiac surgery and defibrillators. These players are focusing on technological advancements, strategic partnerships, and expanding their presence through acquisitions, such as C. R. Bard’s integration into BD, to strengthen their competitive positioning.

Recent Developments

In February 2025, Abbott issued a safety notification for certain Assurity and Endurity pacemakers due to potential epoxy mixing issues during manufacturing, which could lead to device malfunction.

In April 2025, GE HealthCare launched the Revolution™ Vibe CT system featuring Unlimited One-Beat Cardiac imaging and AI solutions, enhancing cardiac imaging capabilities.

In April 2025, Medtronic reported promising evidence for its Affera™ pulsed field ablation technologies in treating atrial fibrillation patients.

In May 2024, Siemens Healthineers announced new cardiology applications with artificial intelligence for the Acuson Sequoia ultrasound system, including a new 4D transesophageal (TEE) transducer for cardiology exams.

In February 2025, Philips developed a miniaturized intracardiac transducer, enabling higher-resolution views of cardiac structures and functions, benefiting structural heart disease and electrophysiology procedures.

In March 2025, Boston Scientific announced the acquisition of SoniVie Ltd. to expand its interventional cardiology therapies offerings with ultrasound-based renal denervation technology.

In June 2024, Biovac Institute entered a partnership with Sanofi to locally manufacture inactivated polio vaccines in Africa, aiming to serve the potential needs of over 40 African countries.

Market Concentration and Characteristics

The UK cardiovascular devices market is moderately concentrated, with a few large multinational companies dominating the landscape. Major players such as Abbott, Medtronic, Boston Scientific, and Edwards Lifesciences hold significant market shares, driven by their extensive product portfolios, technological innovations, and established brand presence. These companies focus on developing advanced diagnostic, therapeutic, and monitoring devices that cater to the growing demand for cardiovascular care. Despite the dominance of key players, there is a presence of niche companies such as BIOTRONIK and LivaNova, which target specific segments like defibrillators and heart surgery technologies. The market is characterized by a high level of innovation, with continuous advancements in minimally invasive procedures, wearable technologies, and AI-based diagnostics. This dynamic environment encourages both competition and collaboration, with players investing in research and development to meet the evolving needs of healthcare providers and patients.

Report Coverage

The research report offers an in-depth analysis based on Product, End User, Diagnostic & Monitoring Devices Type, Surgical Devices Type and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The increasing focus on preventive cardiovascular care will drive demand for early diagnostic tools, enabling patients to manage risk factors like hypertension and cholesterol. Healthcare providers will increasingly adopt advanced monitoring devices to detect heart conditions before they progress.

Wearable cardiovascular devices, such as smartwatches and fitness trackers, will see broader adoption, empowering individuals to monitor their heart health in real-time. These devices will evolve with more accurate sensors and integrated AI, enhancing predictive capabilities.

The trend toward minimally invasive cardiovascular treatments will continue to grow, supported by advancements in catheter-based technologies, stents, and surgical robots. These innovations will improve patient outcomes, reduce recovery times, and lower procedural risks.

AI and machine learning technologies will play a pivotal role in the UK cardiovascular devices market by enhancing diagnostic accuracy and enabling personalized treatment plans. These technologies will optimize decision-making for clinicians and improve overall care quality.

As the UK’s population ages, the demand for cardiovascular devices will increase. Older adults are at a higher risk of heart diseases, thus amplifying the need for advanced diagnostic and therapeutic devices to manage chronic conditions.

Remote patient monitoring will become an integral part of cardiovascular care, particularly for managing chronic conditions like heart failure. This will enable healthcare providers to offer continuous care, even in non-hospital settings, improving patient engagement and reducing hospital readmissions.

With the rising healthcare costs, there will be a growing emphasis on cost-effective cardiovascular devices. Manufacturers will focus on developing affordable yet high-quality solutions to cater to both public and private healthcare providers seeking budget-friendly options.

Evolving regulatory frameworks in the UK will create a favorable environment for new cardiovascular devices. Streamlined approval processes for innovative technologies will accelerate market entry, allowing quicker access to cutting-edge devices for healthcare providers.

The UK government’s commitment to improving healthcare services, especially for cardiovascular diseases, will drive investment in advanced medical technologies. Continued funding will foster the development and adoption of state-of-the-art cardiovascular devices in hospitals and clinics.

The market will see the rise of new entrants focusing on specialized cardiovascular solutions, such as advanced bioabsorbable stents and non-invasive diagnostic tools. These innovations will enhance competition, driving further advancements and improving overall market dynamics.

CHAPTER NO. 1 : INTRODUCTION 17

1.1.1. Report Description 17

Purpose of the Report 17

USP & Key Product 17

1.1.2. Key Benefits for Stakeholders 17

1.1.3. Target Audience 18

1.1.4. Report Scope 18

CHAPTER NO. 2 : EXECUTIVE SUMMARY 19

2.1. Cardiovascular Devices Market Snapshot 19

2.1.1. UK Cardiovascular Devices Market, 2018 – 2032 (USD Million) 20

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 21

3.1. Russia-Ukraine and Israel-Palestine War Impacts 21

CHAPTER NO. 4 : CARDIOVASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 22

4.1. Introduction 22

4.2. Market Drivers 23

4.2.1. Driving Factor 1 Analysis 23

4.2.2. Driving Factor 2 Analysis 24

4.3. Market Restraints 25

4.3.1. Restraining Factor Analysis 25

4.4. Market Opportunities 26

4.4.1. Market Opportunities Analysis 26

4.5. Porter’s Five Force analysis 27

4.6. Value Chain Analysis 28

4.7. Buying Criteria 29

CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 30

5.1. Company Market Share Analysis – 2023 30

5.1.1. UK Cardiovascular Devices Market: Company Market Share, by Revenue, 2023 30

5.1.2. UK Cardiovascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 30

5.1.3. UK Cardiovascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 31

5.2. UK Cardiovascular Devices Market Company Revenue Market Share, 2023 32

5.3. Company Assessment Metrics, 2023 33

5.3.1. Stars 33

5.3.2. Emerging Leaders 33

5.3.3. Pervasive Players 33

5.3.4. Participants 33

5.4. Start-ups /Code Assessment Metrics, 2023 33

5.4.1. Progressive Companies 33

5.4.2. Responsive Companies 33

5.4.3. Dynamic Companies 33

5.4.4. Starting Blocks 33

5.5. Strategic Developments 34

5.5.1. Acquisition & Mergers 34

New Product Launch 34

Regional Expansion 34

5.6. Key Players Product Matrix 35

CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 36

6.1. PESTEL 36

6.1.1. Political Factors 36

6.1.2. Economic Factors 36

6.1.3. Social Factors 36

6.1.4. Technological Factors 36

6.1.5. Environmental Factors 36

6.1.6. Legal Factors 36

6.2. Adjacent Market Analysis 36

CHAPTER NO. 7 : CARDIOVASCULAR DEVICES MARKET – BY PRODUCT SEGMENT ANALYSIS 37

7.1. Cardiovascular Devices Market Overview, by Product Segment 37

7.1.1. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 38

7.1.2. Cardiovascular Devices Market Attractiveness Analysis, By Product 39

7.1.3. Incremental Revenue Growth Opportunities, by Product, 2024 – 2032 39

7.1.4. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 40

7.2. Diagnostic & Monitoring Devices 41

7.2.1. UK Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

7.3. Surgical Devices 43

7.3.1. UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

7.3.2. UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

CHAPTER NO. 8 : CARDIOVASCULAR DEVICES MARKET – BY END USER SEGMENT ANALYSIS 45

8.1. Cardiovascular Devices Market Overview, by End User Segment 45

8.1.1. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 46

8.1.2. Cardiovascular Devices Market Attractiveness Analysis, By End User 47

8.1.3. Incremental Revenue Growth Opportunities, by End User, 2024 – 2032 47

8.1.4. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 48

8.2. Hospitals & Clinics 49

8.3. Diagnostic Laboratories 50

8.4. Ambulatory Surgical Centers 51

8.5. Others 52

CHAPTER NO. 9 : CARDIOVASCULAR DEVICES MARKET – UK 53

9.1. UK 53

9.1.1. Key Highlights 53

9.1.2. UK Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 54

9.2. Product 55

9.3. UK Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 55

9.4. UK Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 55

9.5. Diagnostic & Monitoring Device Types 56

9.5.1. UK Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

9.5.2. UK Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

9.6. Surgical Devices Types 57

9.6.1. UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

9.6.2. UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

9.7. End User 58

9.7.1. UK Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 58

9.7.2. UK Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 58

CHAPTER NO. 10 : COMPANY PROFILES 59

10.1. Abbott 59

10.1.1. Company Overview 59

10.1.2. Product Portfolio 59

10.1.3. Swot Analysis 59

10.1.4. Business Strategy 60

10.1.5. Financial Overview 60

10.2. GE HealthCare 61

10.3. Edwards Lifesciences Corporation 61

10.4. W. L. Gore & Associates, Inc. 61

10.5. Siemens Healthcare GmbH 61

10.6. BIOTRONIK SE & Co. KG 61

10.7. Canon Medical Systems Asia Pte. Ltd. 61

10.8. Cardinal Health 61

10.9. Medtronic 61

10.10. Boston Scientific Corporation 61

10.11. Johnson & Johnson Services, Inc 61

10.12. Flexicare 61

10.13. C. R. Bard (now part of BD) 61

10.14. Smith & Nephew 61

10.15. LivaNova 61

10.16. Others 61

]

List of Figures

FIG NO. 1. UK Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 20

FIG NO. 2. Porter’s Five Forces Analysis for UK Cardiovascular Devices Market 27

FIG NO. 3. Value Chain Analysis for UK Cardiovascular Devices Market 28

FIG NO. 4. Company Share Analysis, 2023 30

FIG NO. 5. Company Share Analysis, 2023 30

FIG NO. 6. Company Share Analysis, 2023 31

FIG NO. 7. Cardiovascular Devices Market – Company Revenue Market Share, 2023 32

FIG NO. 8. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 38

FIG NO. 9. Market Attractiveness Analysis, By Product 39

FIG NO. 10. Incremental Revenue Growth Opportunities by Product, 2024 – 2032 39

FIG NO. 11. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 40

FIG NO. 12. UK Cardiovascular Devices Market for Diagnostic & Monitoring Devices, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. UK Cardiovascular Devices Market for Surgical Devices, Revenue (USD Million) 2018 – 2032 43

FIG NO. 14. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 46

FIG NO. 15. Market Attractiveness Analysis, By End User 47

FIG NO. 16. Incremental Revenue Growth Opportunities by End User, 2024 – 2032 47

FIG NO. 17. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 48

FIG NO. 18. UK Cardiovascular Devices Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 49

FIG NO. 19. UK Cardiovascular Devices Market for Diagnostic Laboratories, Revenue (USD Million) 2018 – 2032 50

FIG NO. 20. UK Cardiovascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 51

FIG NO. 21. UK Cardiovascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 52

FIG NO. 22. UK Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 53

List of Tables

TABLE NO. 1. : UK Cardiovascular Devices Market: Snapshot 19

TABLE NO. 2. : Drivers for the Cardiovascular Devices Market: Impact Analysis 23

TABLE NO. 3. : Restraints for the Cardiovascular Devices Market: Impact Analysis 25

TABLE NO. 4. : UK Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

TABLE NO. 5. : UK Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

TABLE NO. 6. : UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

TABLE NO. 7. : UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

TABLE NO. 8. : UK Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 54

TABLE NO. 9. : UK Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 54

TABLE NO. 10. : UK Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 55

TABLE NO. 11. : UK Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 55

TABLE NO. 12. : UK Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

TABLE NO. 13. : UK Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

TABLE NO. 14. : UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

TABLE NO. 15. : UK Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

TABLE NO. 16. : UK Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 58

TABLE NO. 17. : UK Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 58

Frequently Asked Questions

What is the market size of the UK Cardiovascular Devices Market in 2023 and 2032?

What are the main drivers of the UK Cardiovascular Devices Market?

The main drivers include the rising incidence of cardiovascular diseases, an aging population, and advancements in medical technology. Increased awareness about heart diseases and preventive care is also fueling market demand.

Who are the key players in the UK Cardiovascular Devices Market?

Key players in the UK cardiovascular devices market include Abbott Laboratories, Medtronic, Philips Healthcare, and Boston Scientific, which continue to innovate and expand their product offerings to meet growing market demands.

What role does government healthcare investment play in the UK Cardiovascular Devices Market?

Government healthcare investments in the UK support the growth of the cardiovascular devices market by funding advanced technologies and expanding access to cardiovascular care, particularly for preventive services and treatment.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –